The Platelet Antibodies, Indirect (IgG, IgM, IgA) panel, featuring the Platelet Ab, Indirect (IgG) test, is a critical diagnostic tool in the field of hematology and immunology, particularly in the evaluation of thrombocytopenia (low platelet count) and platelet dysfunction disorders. The Platelet Ab, Indirect (IgG) test specifically measures the presence of immunoglobulin G (IgG) antibodies that are directed against platelets. These antibodies play a significant role in various autoimmune conditions, where the body’s immune system mistakenly targets and destroys its own platelets, leading to a decreased platelet count. Conditions such as Immune Thrombocytopenia (ITP), in which IgG antibodies bind to platelets and enhance their destruction in the spleen, are commonly diagnosed with the help of this test. Additionally, this test is instrumental in evaluating patients for possible drug-induced thrombocytopenia, where certain medications stimulate the production of platelet-directed antibodies, and in post-transfusion purpura, a rare but serious condition following blood transfusion. The Platelet Ab, Indirect (IgG) test in the comprehensive panel offers vital information for diagnosing, monitoring, and managing these complex conditions. Its accurate and sensitive detection of IgG antibodies against platelets is crucial in guiding treatment strategies, including immunosuppressive therapy or platelet transfusion management.
Platelet Ab, Indirect (IgG)
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →
All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.